Biotech RadarJobs updated

COMPANY

Phraxis

phraxis.com ↗

FDA-cleared device company

Profile checked Oct 10, 2026

Keywords: End Stage Renal Disease Dialysis Access Malfunction Venous InterGraft Connector VIG Continued Access Study

3Trials (company is sponsor)

Timeline

  1. Trial start —: EndoForce Post Approval Study source ↗
  2. Trial start Not phased (device or behavioral study): Continued Access Study VIG Anastomotic Connector source ↗
  3. Trial start Not phased (device or behavioral study): Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study] source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 3

RecordTitlePhaseStatusStartPrimary completion
NCT07146854EndoForce Post Approval StudyNot listedRecruitingJan 13, 20262029-12 (estimated)
NCT02532621Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]Not phased (device or behavioral study)CompletedFeb 21, 2018Jan 19, 2022 (actual)
NCT05448950Continued Access Study VIG Anastomotic ConnectorNot phased (device or behavioral study)CompletedJun 7, 2022Mar 8, 2023 (actual)
Feedback